MedPage Today on MSN

FDA opens door to quicker approval of osteoporosis drugs

The surrogate endpoint offers an alternative to traditional fracture endpoints used in clinical trials of osteoporosis drugs ...
Healio

Baseline BMD T-score can help determine first-line therapy for women with osteoporosis

Please provide your email address to receive an email when new articles are posted on . Researchers calculated the likelihood of achieving a BMD T-score of –2.5 or higher with denosumab based on ...
Healio

BMD loss seen in early adulthood for women, despite healthy behaviors

Please provide your email address to receive an email when new articles are posted on . A menarche-centered model assessing age at peak bone mineral density suggests bone loss women may begin as soon ...
The News International

Tea drinkers may have stronger bones than coffee consumers, study suggests

A decade-long study by Flinders University shed new light on two most frequently consumed drinks; tea and coffee and their ...
Medscape

What Is BMD’s Impact as a Surrogate Osteoporosis Endpoint?

SEATTLE — Researchers who have established the level of bone mineral density (BMD) change that can serve as a surrogate endpoint in anti-osteoporosis drug clinical trials have now also determined the ...